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ABSTRACT 
Snake envenomations have been a serious yet often overlooked public health threat especially in tropical and 
subtropical countries, including Southeast Asia. The medically important venomous land snakes in Southeast Asia 
include snakes from the Elapidae and Crotalidae families. Among the elapids, there are only 12 species that are 
considered of medical importance, represented by the kraits (Bungarus caeruleus, B. candidus, B. fasciatus, B. 
flaviceps and B. multicinctus). The incidence of snakebite is high in India. Apart from mortality, the morbidity is due to 
various complications. The common krait (Bungarus caeruleus) is the most toxic snake found commonly in the plains 
of throughout the India and the number of snakebites in the rural areas of India was recorded by this snake. The present 
article highlights the prevalence and the clinical complications of Indian common krait envenomation among the rural 
populations of India. 
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INTRODUCTION 
Alexander the Great who invaded India in 326 BC, was 
greatly impressed by the skills of Indian physicians, 
especially in the treatment of snakebites (Jaggi, 2000). 
Since then, India has remained notorious for its 
venomous snakes and the effects of their bites. With its 
surrounding seas, India is inhabited by more than 60 
species of venomous snakes, some of which are 
abundant and can cause severe envenoming (Whitaker, 
2004). 
Snake envenomations have been a serious yet often 
overlooked public health threat especially in tropical and 
subtropical countries, including Southeast Asia 
(Kasturiratne et al., 2008; Chippaux, 2006). The 
medically important venomous land snakes in Southeast 
Asia include snakes from the Elapidae and Crotalidae 
families. Among the elapids, there are only 12 species 
that are considered of medical importance, represented 
by the kraits (Bungarus caeruleus, B. candidus, B. 
fasciatus, B. flaviceps and B. multicinctus), the Asiatic 
cobras (including Naja kaouthia, N. sumatrana, N. 
siamensis, N. sputatrix, N. philippinensis and N. atra), 
and the king cobra (Ophiophagus hannah) (Warrell, 
1999). 
The incidence of snakebite is high in India. Apart from 
mortality, the morbidity is due to various complications 
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(Narvencar, 2006). Approximately 10000 to 50000 
snakebite related deaths occur in India each year 
(McNamee, 2001). A majority of the deaths are caused 
by neurotoxic envenoming by kraits and cobras in 
India’s rural population (McNamee, 2001; Warrell, 
1999). Snakebite is common in subtropical countries 
with heavy rainfall and humid climates (Banerjee, 1978). 
Snake bite affects South Asia than anywhere else in the 
world with very high morbidity and mortality. 
Identification of the offending snake often facilitates 
clinical management of the patient (Alirol, et al., 2010). 
Awareness of the fact had led the public to carry 
offending snakes killed or alive, to hospital together with 
snake bite victims when possible. However, even if the 
offending snake is authenticated, incorrect 
authentications also had led to inappropriate 
management (Nishioka and Silveira, 1994; Ariaratnam 
et al., 2009). 
Some snake species are often misidentified due to 
morphological resemblance to other snakes. For 
example, highly venomous Kraits are often misidentified 
as non-venomous Wolf snakes or vise-versa due to 
notoriously similar colour patterns (Fernando, 1997). 
Immunodiagnostic techniques like Enzyme linked 
Immunosorbent Assay is increasingly being used to 
accurately authenticate the offending snake in snake bite 
cases in some countries (Ho et al., 1986). However, 
since these techniques are not yet available in routine 
practice in India, conventional snake identification 
methods like morphological studies are still useful. 
Indian common krait (Bungarus caereulus) 
The B. caeruleus snake has strong neurotoxic venom, 
envenomation by B. caeruleus causes hemorrhage, tissue 
necrosis and hemostatic disorders in the experimental 
animal. Furthermore, it shows high proteolytic activity 
towards casein and human fibrinogen (Rajana et al., 
2013).  
The common krait (Bungarus caereulus) is regarded as 
the most dangerous species of venomous snake in the 
Indian subcontinent (Theakston et al., 1990). The most 
villagers in India usually sleep on the floor of their area, 
which are often surrounded by dense vegetation 
(Bawaskar, 2002). Although not vicious by nature, the 
krait may strike a person sleeping on the ground if the 
person accidentally touches or rolls over onto the snake 
(Kulartane, 1997). Also, the snake could mistakenly 
identify an exposed body part as prey. Most bites occur 
during the cooler months of June to December when 
snakes may, during the course of their hunting activity, 
linger in a person’s bedding to take advantage of the 
warmth therein (Bawaskar, 2002; Kulartane, 1997). The 
common krait (Bungarus caeruleus) is the most toxic 
snake found commonly in the plains of Northwest India 
and bites typically occur during July—September 
(Sharma et al., 2005; Chauhan et al., 2005; Aggarwal et 
al., 2005). Kraits are elapid snakes and within the single 
genus Bungarus, 12 species are found (Keogh, 1998). 
They are generally nocturnal, shy and non-aggressive. 
Their diet consists of other snakes and it will therefore 
pursue them into human habitation, where the prey 
species are hunting for rodents. Bites generally occur 
when kraits are disturbed by sleeping humans moving, 
either naturally, or during rapid eye movement (REM) 
sleep (Kularatne, 2002). 
The major neurotoxic component of krait venom is β-
bungarotoxin, which has high affinity for presynaptic 
neuromuscular receptors. It irreversibly blocks these 
receptors and is completely resistant to 
anticholinesterase treatment (Watt et al., 1986). 
Components of krait venom 
Krait venom possess a wide variety of toxins and 
enzymes including neurotoxins, membrane toxins, 
cardiotoxins, 3 finger toxins (3FTXs), PLA2s, 
metalloproteinases, cholinesterases, L-amino acid 
oxidases, serine proteases etc. (Rusmili et al, 2014). α-
bungarotoxin, the first postsynaptic neurotoxin isolated 
from Bungarus multicinctus, inhibited the response of 
acetylcholine receptor on motor endplate and 
irreversibly blocked the transmission (Chang and Lee, 
1963; Lee and Chang, 1966; Jiang et al, 1986). The 
other postsynaptic neurotoxins isolated from Bugnagus 
sp. include TI, TH, κ-bungarotoxin, κ 2-bungarotoxin 
and κ 3-bungarotoxin, ceruleotoxin, alphaN3 and Bucain 
(Hsu et al, 1985; Grant and Chiappinelli, 1985; 
Chiappinelli et al, 1990; Bon et al, 1975; Karsani and 
Othman, 2009; Murakami et al, 2009). β-bungarotoxin, 
γ-bungarotoxin and Toxin F are presynaptic neurotoxins 
isolated from Bugnagus sp. Venom (Chang and Lee, 
1963; Rehm and Betz, 1984; Tsai et al, 2007; Chang et 
al, 2002; Loring et al, 1984). Phospholipase A2 (PLA2) 
is also an important constituent of Bungarus sp. venom 
(Liu et al., 1988; Liu et al., 1989; Khow et al., 2002; 
Tsai et al, 2007). The enzyme L-amino acid oxidase 
(LAAO) found in Bungagus sp. venom plays a major 
role in inducing toxicity (More et al, 2010; Wei et al, 
2009). A number of protease inhibitors have been 
identified from krait venom (Zhang et al, 1995; Lu et al., 
2008; Chen et al., 2015; Siang et al., 2010; Khow et al., 
2003). Cholinesterase was also purified from B. 
fasciatus venom through fractional precipitation with 
ammonium sulfate (Ghosh and Chaudhuri, 1968). 
Clinical complications of Krait venom: 
Envenoming due to krait (Genus: Bungarus) bites is a 
common, serious health issue in South and South-East 
Asia. Common krait (Bungarus caeruleus) is distributed 
throughout South Asia, and is responsible for large 
numbers of cases of severe neurotoxic envenoming each 
year (Valenta, 2010). It results in a descending flaccid 
paralysis progressing to life threatening respiratory 
paralysis unless mechanical ventilation is available 
(Alirol et al., 2010; Pe et al., 1997; Kularatne, 2002). 
Krait bites typically occur at night and are not painful; 
so many patients do not notice the bite and continue 
sleeping (Bawaskar and Bawaskar, 2004; Warrell et al., 
1983; Ariaratnam et al., 2008), which delays medical 
care. Neuromuscular paralysis in krait envenoming is 
characterized by progressive descending paralysis. Krait 
venom contains β-bungarotoxins, which are presynaptic 
neurotoxins with phospholipase A activity and 
considered to be the major cause of paralysis. The pre-
synaptic action is irreversible and is the reason that once 
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paralysis develops it is not reversed with antivenom 
(Dixon, 1999). 
The pathophysiology of neuromuscular paralysis in 
snake envenoming remains poorly understood. This is 
due to the lack of detailed clinical studies of 
authenticated bites that report the time course of 
paralysis, including the recovery of paralysis, and very 
few studies of neurophysiological function in snake 
envenoming. There is also little evidence for the 
effectiveness of antivenom in reversing neuromuscular 
paralysis (Johnston, et al., 2012). Neurophysiological 
testing could provide objective evidence of the 
progression and recovery of neurotoxicity, and the 
response to antivenom. Previous neurophysiological 
testing in krait bites with nerve conduction studies and 
repetitive nerve stimulation tests provide some 
information on krait neurotoxicity. Single fibre electro-
myography (sfEMG) is a more sensitive test of 
neuromuscular function (Richardson, et al., 2007). It has 
only been reported in one study of neuromuscular 
paralysis from Papuan taipan envenoming (Sanders, 
2002). Better methods to measure neuromuscular 
dysfunction in neurotoxic envenoming will improve our 
understanding of neuromuscular paralysis and the 
clinical benefit of antivenom. 
Clinical complications: 
Indian Krait is distributed in India, Bangladesh, 
Pakistan, Nepal and Sri Lanka. Bites by these snakes 
lead to high morbidity and mortality in the region, often 
leading to death of the victim, if not intervened (Warrell, 
1995). Indian Krait is known to cause most of the bites 
during night, when the victim is sleeping (Kularatne, 
2002). Indian Kraits cause a clinical syndrome 
characterized by negligible local envenoming, vomiting, 
abdominal pain and descending paralysis that at times 
start as soon as 30 min after the bite which could be 
delayed for up to 4 h (Ariaratnam et al., 2008). Although 
ptosis, external opthalmoplegia, dysphagia, drowsiness, 
altered consciousness and deep coma also had been 
commonly reported following envenoming by this 
snake, reports on prolonged WBCT in Indian Krait bite 
victims has been very rare (Kularatne, 2002). On the 
contrary, Sri Lankan Russell’s viper (Daboia russelli) 
frequently causes both neurotoxicity and coagulopathy 
in the victims (Kularatne, 2003). However, Kularatne 
reported mottling haemorrhages in viscera and adrenal 
bleeding in one victim of Indian Krait who died due to 
shock, however with no clinical details (Kularatne, 
2002). In addition, the same study revealed occurrence 
of mucosal haemorrhages in stomach of 3 of the 16 
deceased victims of Indian Krait bite. Therefore, altered 
coagulation and haemorrhages as evident from the 
laboratory and post-mortem findings of the victim 
suggest rare clinical presentations of anti-coagulant 
effects of Indian Krait venom. 
Treatment of Snakebite: 
The treatment of snakebite is as variable as the bite 
itself. The only available treatment is the usage of 
antivenom against snakebite. The first antivenom (called 
an anti-ophidic serum) was developed by Albert 
Calmette, a French scientist of the Pasteur Institute in 
1895, against the Indian cobra (Naja naja). Antivenom 
binds to and neutralizes the venom, stopping further 
damage, but do not reverses the damage already done. 
Some individuals may react to the antivenom with 
immediate hypersensitivity reactions. Other alternative 
treatment involves the usage of folk and traditional 
medicines in snake bites. Medicinal herbs are the local 
heritage in the global importance. Various plants have 
been used against snake bite, in folk and traditional 
medicine. In Ayurvedic system of medicine different 
plants and their compounds are reported to possess 
antisnake venom activity. But they also possess these 
individual toxicities and most of the folk medicinal 
plants have no scientific validation (Gomes et al., 2010; 
Cannon et al., 2008). 
Currently, a large number of plants and plant materials 
are being screened for pharmacological activities 
especially those used in traditional or folk medicine 
against different diseases. Over the years, many attempts 
have been made for the development of snake venom 
antagonists especially from plant sources in spite of the 
existence of antiserum. Many Indian medicinal plants or 
plant materials are recommended for the treatment of 
snakebite and some are tested, but so far no systematic 
analysis has been done (Alam and Gomes, 2003; 
Chopra, et al., 1956; Nazimudeen et al., 1978). 
The common krait (Bungarus caeruleus) is the most 
toxic snake found commonly in the plains of Northwest 
India and bites typically occur during July—September 
(Sharma et al., 2005; Chauhan et al., 2005; Aggarwal et 
al., 2005). Kraits are elapid snakes and within the single 
genus Bungarus, 12 species are found (Keogh, 1998). 
They are generally nocturnal, shy and non-aggressive. 
Their diet consists of other snakes and it will therefore 
pursue them into human habitation, where the prey 
species are hunting for rodents. Bites generally occur 
when kraits are disturbed by sleeping humans moving, 
either naturally, or during rapid eye movement (REM) 
sleep (Kularatne, 2002). A significant number of patients 
die before they reach the hospital, largely due to the fact 
that the bite does not inflict sufficient pain or as a result 
of the bite itself or venom action and the victims are 
therefore unaware that they have been bitten. 
Common venomous snakes found in the Indian 
subcontinent are kraits, cobras, and carpet vipers (Echis 
carinatus). Kraits are nocturnal, terrestrial snakes that 
enter human dwellings in search of prey such as rats, 
mice, and lizards (Bawaskar, 2002).  
Spectacled cobra (Naja naja), common krait (Bungarus 
caeruleus), saw-scaled viper (Echis carinatus) and 
Russell's viper (Daboia russelii) have long been 
recognised as the most important, but other species may 
cause fatal snakebites in particular areas, such as the 
central Asian cobra (Naja oxiana) in the far north-west, 
monocellate cobra (N. kaouthia) in the north-east, 
greater black krait (B.niger) in the far north-east, Wall's 
and Sind kraits (B. walli and B. sindanus) in the east and 
west and hump-nosed pit-viper (Hypnale hypnale) in the 
south-west coast and Western Ghats (Whitaker, 2004). 
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Herbal remedies for Snakebite 
Extracts from plants have been used among traditional 
healers, especially in tropical areas where there are 
plentiful sources, as therapy for snakebite for a long 
time. Several medicinal plants, which appear in old drug 
recipes or which have been passed on by oral tradition, 
are believed to be snakebite antidotes. Many Indian 
medicinal plants are recommended for the treatment of 
snakebite (Meenatchisundaram et al., 2008). Accurate 
records to determine the exact epidemiology or even 
mortality of snake bite cases are generally unavailable. 
Hospital records fall far short of the actual number, 
owing to dependence on traditional healers and 
practitioners of witchcraft, especially in developing 
countries. It has been reported that in most developing 
countries, up to 80% of individuals bitten by snakes first 
consult traditional practitioners before visiting a medical 
centre. Owing to the delay, several victims die during 
journey to the hospital (Hasson et al., 2009) 
CONCLUSION 
Snakebite is being one of the dangerous health hazards 
in tropical countries especially in India. The data present 
in this paper will help the reader to understand the snake 
venom, Indian common krait, composition of krait 
venom and the clinical complications of the krait bite 
treatment.
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